| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
41,610,000 |
| Market
Cap: |
83.22(M) |
| Last
Volume: |
1,136,985 |
Avg
Vol: |
1,133,856 |
| 52
Week Range: |
$0.900001 - $2.955 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Media |
| Level
III Sector: |
Broadcasting - TV |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Brooklyn ImmunoTherapeutics is a clinical-stage biopharmaceutical company focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. Co. is seeking to develop IRX-2, a cytokine-based therapy, to treat patients with cancer. Co. also is exploring opportunities to advance oncology, blood disorder, and monogenic disease therapies using gene-editing and cell therapy technology through a license with Factor Bioscience Limited and through its subsidairies, Novellus, Inc. and Novellus, Ltd.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
880,962 |
| Total Buy Value |
$0 |
$0 |
$0 |
$2,889,556 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Krishnan Ram |
CEO |
• • – |
2018-09-25 |
4 |
D |
$4.23 |
$6,095 |
D/D |
(1,441) |
75,177 |
|
- |
|
| Gurrola Sandra M |
VP of Finance |
• – – |
2018-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,304 |
|
- |
|
| Krishnan Ram |
CEO |
• • – |
2018-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
76,618 |
|
- |
|
| Wolff Allen |
CFO and EVP |
• – – |
2018-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
50,716 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2018-03-14 |
4 |
S |
$6.24 |
$174,849 |
I/I |
(28,000) |
251,562 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2018-03-13 |
4 |
S |
$6.73 |
$30,900 |
I/I |
(4,426) |
279,562 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2018-03-12 |
4 |
S |
$6.72 |
$29,385 |
I/I |
(4,253) |
283,988 |
|
- |
|
| Simtob Richard Isaac |
Director |
– • – |
2017-12-18 |
4 |
B |
$4.00 |
$22,208 |
D/D |
5,552 |
52,088 |
2.39 |
- |
|
| Simtob Richard Isaac |
Director |
– • – |
2017-12-15 |
4 |
B |
$3.90 |
$390 |
D/D |
100 |
46,536 |
2.31 |
- |
|
| Simtob Richard Isaac |
Director |
– • – |
2017-12-07 |
4 |
B |
$3.95 |
$19,792 |
D/D |
5,000 |
46,436 |
2.39 |
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-11-30 |
4 |
S |
$5.05 |
$25,251 |
I/I |
(5,000) |
288,241 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-11-29 |
4 |
S |
$5.11 |
$36,092 |
I/I |
(7,061) |
293,241 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-11-28 |
4 |
S |
$5.08 |
$55,231 |
I/I |
(10,774) |
300,302 |
|
- |
|
| Simtob Richard Isaac |
Director |
– • – |
2017-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,337 |
40,254 |
|
- |
|
| Thomas Gregory Matthew |
Director |
– • – |
2017-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,337 |
2,337 |
|
- |
|
| Mitgang Steve |
Director |
– • – |
2017-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
816 |
1,813 |
|
- |
|
| Berg Jeffrey Alan |
Director |
– • • |
2017-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
919 |
12,346 |
|
- |
|
| Yanover Paul |
Director |
– • – |
2017-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
612 |
1,163 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-09-18 |
4 |
S |
$7.25 |
$624 |
I/I |
(86) |
311,076 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-09-11 |
4 |
S |
$7.25 |
$2,153 |
I/I |
(297) |
311,162 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-09-08 |
4 |
S |
$7.25 |
$73 |
I/I |
(10) |
311,459 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-08-30 |
4 |
S |
$7.41 |
$4,446 |
I/I |
(600) |
312,019 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-08-29 |
4 |
S |
$7.43 |
$11,886 |
I/I |
(1,600) |
312,619 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-08-28 |
4 |
S |
$7.42 |
$742 |
I/I |
(100) |
314,219 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-08-25 |
4 |
S |
$7.41 |
$3,290 |
I/I |
(444) |
314,319 |
|
- |
|
232 Records found
|
|
Page 7 of 10 |
|
|
0.03 (1.48%) 
